Applovin Corp (APP) Earnings Beat Projections
Applovin Corp (NASDAQ:APP) is among the best S&P 500 stocks with highest upside potential.
Insider Monkey Blog
Oracle Corp (ORCL)’s Upside Potential: Federal Wins and Market Confidence
Oracle Corp (NYSE:ORCL) is among the best S&P 500 stocks with highest upside potential.
12 Best Stocks Under $50 to Invest In
On February 4, Stephen Parker, JPMorgan Private Bank co-head of global investment strategy, joined 'Squawk Box' on CNBC to discuss the latest market trends and the 2026 outlook...
Morgan Stanley Reduces PT on Twilio Inc. (TWLO) Stock
On February 13, Morgan Stanley reduced its price objective on the company’s stock to $153 from $169, while keeping an “Overweight” rating, as reported by The Fly.
Bright Horizons Family Solutions Inc. (BFAM) Reports Fourth-Quarter Revenue of $734 Million, Ahead of Consensus
On February 12, 2026, Bright Horizons Family Solutions Inc. (NYSE:BFAM) reported fourth-quarter revenue of $734 million, ahead of the consensus estimate of $727.44 million.
Birkenstock Holding plc (BIRK) Reports First-Quarter Revenue of EUR 401.9 Million, Up from EUR 361.72 Million
On February 12, 2026, Birkenstock Holding plc (NYSE:BIRK) reported first-quarter revenue of EUR 401.9 million, up from EUR 361.72 million a year earlier.
Dutch Bros Inc. (BROS) Reports Fourth-Quarter Revenue of $443.6 million, Above Consensus
On February 12, 2026, Dutch Bros Inc. (NYSE:BROS) reported fourth-quarter revenue of $443.6 million, above the consensus estimate of $424.9 million.
BMO Capital Lowers its Price Target on McGraw Hill, Inc. (MH) to $19 and Maintains an Outperform Rating
On February 12, 2026, BMO Capital lowered its price target on McGraw Hill, Inc. (NYSE:MH) to $19 from $21 and maintained an Outperform rating.
Goldman Sachs Lowers its Price Target on H&R Block, Inc. (HRB) to $32 and Maintains a Sell Rating
On February 6, 2026, Goldman Sachs lowered its price target on H&R Block, Inc. (NYSE:HRB) to $32 from $48 and maintained a Sell rating.
BofA Lowers its Price Target on Etsy, Inc. (ETSY) to $63 and Maintains a Neutral Rating
On February 11, 2026, BofA lowered its price target on Etsy, Inc.
Stephens Upgrades Boot Barn Holdings, Inc. (BOOT) to Overweight from Equal Weight and Raises its Price Target to $237
On February 6, 2026, Stephens upgraded Boot Barn to Overweight from Equal Weight and raised its price target to $237 from $196.
Jefferies Initiates Coverage of Kontoor Brands, Inc. (KTB) with a Hold Rating and a $65 Price Target
On February 4, 2026, Jefferies initiated coverage of Kontoor Brands, Inc. (NYSE:KTB) with a Hold rating and a $65 price target.
Jefferies Initiates Coverage of Levi Strauss & Co. (LEVI) with a Buy Rating and a $25 Price Target
On February 4, 2026, Jefferies analyst Blake Anderson initiated coverage of Levi Strauss & Co. (NYSE:LEVI) with a Buy rating and a $25 price target.
DA Davidson Lowers its Price Target on Harley-Davidson, Inc. (HOG) to $25 and Maintains a Buy Rating
On February 12, 2026, DA Davidson lowered its price target on Harley-Davidson, Inc. (NYSE:HOG) to $25 from $30 and maintained a Buy rating.
TD Cowen Lowers its Price Target on Capri Holdings Limited (CPRI) to $26 and Maintains a Buy Rating
On February 4, 2026, TD Cowen analyst Oliver Chen lowered his price target on Capri Holdings Limited (NYSE:CPRI) to $26 from $32 and maintained a Buy rating.
RBC Capital Lowers its Price Target on Coty Inc. (COTY) to $8 and Maintains an Outperform Rating
On February 9, 2026, RBC Capital lowered its price target on Coty Inc. (NYSE:COTY) to $8 from $10 and maintained an Outperform rating.
Canaccord Lowers its Price Target on Pagaya Technologies Ltd. (PGY) to $32 and Maintains a Buy Rating
On February 10, 2026, Canaccord lowered its price target on Pagaya Technologies Ltd. (NASDAQ:PGY) to $32 from $39 and maintained a Buy rating.
Wedbush Lowers its Price Target on FuboTV Inc. (FUBO) to $3.50 and Maintains an Outperform Rating
On February 5, 2026, Wedbush lowered its price target on FuboTV Inc. (NYSE:FUBO) to $3.50 from $5 and maintained an Outperform rating.
Piper Sandler Lowers its Price Target on Asana, Inc. (ASAN) to $14 and Maintains an Overweight Rating
On February 3, 2026, Piper Sandler lowered its price target on Asana, Inc. (NYSE:ASAN) to $14 from $19 and maintained an Overweight rating following a transfer of coverage.
Genius Sports Limited (GENI) Announces a Partnership with WPP Media
On February 10, 2026, Genius Sports Limited (NYSE:GENI) announced a partnership with WPP Media to support brand investment in sports using Genius Sports’ Fan Graph and FANHub...
Scotiabank Lowers its Price Target on Rapid7, Inc. (RPD) to $9 and Maintains a Sector Perform Rating
On February 11, 2026, Scotiabank analyst Patrick Colville lowered his price target on Rapid7, Inc.
Evercore ISI Lowers its Price Target on MNTN, Inc. (MNTN) to $27 and Maintains an Outperform Rating
On February 11, 2026, Evercore ISI lowered its price target on MNTN, Inc.
RBC Capital Lowers its Price Target on PagerDuty, Inc. (PD) to $9 and Maintains a Sector Perform Rating
On February 11, 2026, RBC Capital analyst Matthew Hedberg lowered his price target on PagerDuty, Inc.
Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating
On February 4, 2026, Barclays raised its price target on CytomX Therapeutics, Inc.
Goldman Sachs Lowers its Price Target on Upwork Inc. (UPWK) to $27 and Maintains a Buy Rating
On February 11, 2026, Goldman Sachs lowered its price target on Upwork Inc. (NASDAQ:UPWK) to $27 from $28 and maintained a Buy rating.
JPMorgan Lowers its Price Target on Coursera, Inc. (COUR) to $10 and Keeps an Overweight Rating
On February 9, 2026, JPMorgan lowered its price target on Coursera, Inc. (NYSE:COUR) to $10 from $12 and kept an Overweight rating.
Amprius Technologies, Inc. (AMPX) Announces a Manufacturing Partnership with Nanotech Energy
On February 3, 2026, Amprius Technologies, Inc.
Wedbush Lowers its Price Target on Tripadvisor, Inc. (TRIP) to $15 and Maintains a Neutral Rating
On February 6, 2026, Wedbush analyst Scott Devitt lowered his price target on Tripadvisor, Inc. (NASDAQ:TRIP) to $15 from $18 previously and maintained a Neutral rating.
Stifel Lowers its Price Target on The Wendy’s Company (WEN) to $9 and Maintains a Hold rating
On February 6, 2026, Stifel analyst Chris O'Cull lowered his price target on The Wendy's Company (NASDAQ:WEN) to $9 from $11 previously and maintained a Hold rating.
Fastly, Inc. (FSLY) Reports Fourth-Quarter Revenue of $172.61 million, Ahead of Consensus
On February 12, 2026, Fastly, Inc. (NASDAQ:FSLY) reported fourth-quarter revenue of $172.61 million, ahead of the $161.36 million consensus estimate.
Texas Capital Downgrades Great Lakes Dredge & Dock Corporation (GLDD) to Hold with a $17 Price Target
On February 12, 2026, Texas Capital analyst Alex Rygiel downgraded Great Lakes Dredge to Hold from Buy with a $17 price target after Saltchuk Resources announced a definitive ...
DHT Holdings (DHT) Beats Forecasts in Q4 2025 Results
DHT Holdings, Inc. (NYSE:DHT) reported strong results for Q4 2025 on February 4, beating expectations in both earnings and revenue.
Enbridge (ENB) Hits a New High Following Impressive Q4 2025 Results
Enbridge Inc. (NYSE:ENB) rose to an all-time high this week after posting strong results for Q4 2025 on February 13.
Solaris Energy Infrastructure (SEI) Surges Following AI Data Center Deal
The share price of Solaris Energy Infrastructure, Inc.
Imperial Petroleum (IMPP) Authorizes $10 Million Share Repurchase Program
The share price of Imperial Petroleum Inc.
Antero Midstream (AM) Reports Results for Q4 2025
The share price of Antero Midstream Corporation (NYSE:AM) surged by 11.84% between February 6 and February 13, 2026, putting it among the Energy Stocks that Gained the Most This...
The Williams Companies (WMB) Surged This Week. Here is Why
The share price of The Williams Companies, Inc.
Excelerate Energy (EE) Price Target Raised by $9
The share price of Excelerate Energy, Inc.
Here is Why Noble Corporation (NE) Jumped This Week
The share price of Noble Corporation plc (NYSE:NE) surged by 16.89% between February 6 and February 13, 2026, putting it among the Energy Stocks that Gained the Most This Week...
Valaris (VAL) Soars Following Merger News with Transocean
Valaris Limited (NYSE:VAL) skyrocketed on February 10 following reports that Transocean had agreed to acquire the company in an all-stock deal valued at around $5.8 billion, creating...
12 Dividend Stocks With High Insider Buying
Dividend policy has taken the spotlight again among the investors’ discussions in the U.S.
10 AI Stocks to Watch: Broadcom, AMD, and More
According to Gartner, Inc., a business and technology insights company, global spending on artificial intelligence is forecast to total $2.52 trillion in 2026, a 44% increase ...
Hedge Fund and Insider Trading News: George Soros, Bill Ackman, Warren Buffett, Steve Cohen, Elliott Management, L1 Capital, Citadel Investment Group, Mattel Inc (MAT), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
11 Best Canadian Growth Stocks to Buy According to Hedge Funds
For over 10 years, U.S. equities have dominated global markets, but that leadership is beginning to show signs of fatigue in 2025. Valuation gaps illustrate the shift: U.S.
11 Best Entertainment Stocks to Buy According to Wall Street
Entertainment stocks are back in the conversation as investors look beyond the narrow list of sectors that defined much of the past two years.
Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study
On February 12, Qize Ding from Rothschild & Co Redburn downgraded the rating on Arcellx Incorporated (NASDAQ:ACLX) from Buy to Neutral.
Here is Why Apogee Therapeutics (APGE) Appears Attractive
On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics (NASDAQ:APGE), with a $95 price target.
Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)
Rama believes the shares offer strong upside potential from the current trading range.
Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026
As of the close of play on February 12, consensus sentiment around Spyre Therapeutics (NASDAQ:SYRE) was strongly bullish.
Hedge Fund Resource Center
